-
Cardiosignal 75، Infective endocarditis prophylaxis in elective surgeries MVR patient
September 1, 2024Cardiosignal 75
-
Cardiosignal 74، Non-cardiac surgery in asymptomatic MR
August 31, 2024Cardiosignal 74
-
ChamberSight 05: Assessment of PAP
August 19, 2024ChamberSight 05
-
ChamberSight 04: RWMA
August 19, 2024ChamberSight 04
-
ChamberSight3: TR severity
August 3, 2024ChamberSight3
-
ChamberSight2: RWMA
July 28, 2024ChamberSight2
-
ChamberSight1: EF and RWMA
June 28, 2024ChamberSight 1
-
CardioSignal 73
March 13, 2024CardioSignal 73
-
CardioSignal 70
February 28, 2024CardioSignal 70
-
CardioSignal 72
February 11, 2024CardioSignal 72
-
CardioSignal 71
January 11, 2024CardioSignal 71
-
CardioSignal 69
January 3, 2024CardioSignal 69
-
CardioSignal 68
December 10, 2023CardioSignal 68
-
CardioSignal 67
December 8, 2023CardioSignal 67
-
CardioSignal 66
October 30, 2023CardioSignal 66
-
CardioSignal 65
September 27, 2023CardioSignal 65
-
CardioSignal 64
September 27, 2023CardioSignal 64
-
CardioSignal 63
September 17, 2023CardioSignal 63
-
CardioSignal 62
August 12, 2023CardioSignal 62
-
CardioSignal 61
August 12, 2023CardioSignal 61
-
CardioSignal 60
August 2, 2023CardioSignal 60
-
CardioSignal 59
July 18, 2023Indication of echocardiography in pre-op assessment
-
CardioSignal 58
July 18, 2023Extended anticoagulation after DVT
-
CardioSignal 56
July 18, 2023Anticoagulation in paroxysmal atrial fibrillation
-
CardioSignal 55
July 18, 2023Indications for DPI in CCS
-
CardioSignal 57
April 16, 2023Management of Mitral Stenosis
-
CardioSignal 55
March 7, 2023Indications of DPI in CCS
-
Cardio-Signal 54
January 3, 2023prophylactic anticoagulation in nonorthopedic surgical patients
-
Cardio-Signal 53
October 16, 2022Management of aortic root dilation due to bicuspid aortic valve
-
Cardio-Signal 52
September 10, 2022Infective Endocarditis prophylaxis in patients with ICD
-
Cardio-Signal 51
August 5, 2022Management of antithrombotic therapy after prosthetic valve implantation
-
Cardio-Signal 50
August 5, 2022Management of Rheumatic Mitral Stenosis
-
Cardio-Signal 49
June 19, 2022Extended oral anticoagulation after pulmonary embolism
-
Cardio-Signal 48
May 20, 2022Management of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
-
Cardio-Signal 47
May 15, 2022Management of hypertriglyceridemia
-
Cardio-Signal 46
May 1, 2022Management of Mitral Stenosis
-
Cardio-Signal 45
April 30, 2022DPI in high risk post-MI patients
-
Cardio-Signal 44
April 25, 2022Screening for asymptomatic carotid stenosis
-
Cardio-Signal 43
April 17, 2022Management of Mitral valve regurgitation
-
Cardio-Signal 42
April 16, 2022Extended anticiagulation after DVT
-
Cardio-Signal 41
March 25, 2022Antithrombotic management prior to dental procedures
-
Cardio-Signal 40
March 25, 2022Antithrombotic therapy for valve prostheses
-
Cardio-Signal 39
March 12, 2022Statins for the primary prevention of ASCVD
-
Cardio-Signal 38
January 30, 2022Secondary prophylaxis of rheumatic heart disease
-
Cardio-Signal 37
January 30, 2022Antithrombotic therapy in valve prostheses
-
Cardio-Signal 36
December 30, 2021management of Tricuspid regurgitation
-
Cardio-Signal 35
December 22, 2021Apixaban dose adjustment
-
Cardio-Signal 34
December 12, 2021Antithrombotic therapy for valve prostheses
-
Cardio-Signal 33
December 12, 2021Management of aortic regurgitation
-
Cardio-Signal 32
November 7, 2021Interpretation of exercise stress test
-
Cardio-Signal 31
September 24, 2021 -
Cardio-Signal 30
September 22, 2021Pre-operative management of NOACs
-
Cardio-Signal 29
September 22, 2021SGLT2 inhibitors in HFrEF
-
Cardio-Signal 28
September 22, 2021Long-term follow-up of coarctation of aorta
-
Cardio-Signal 27
September 22, 2021Aortic Coarctation follow-up
-
Cardio-Signal 26
September 8, 2021ICD implantation in HCM
-
Cardio-Signal 25
September 8, 2021NOACs in valvular AF
-
Cardio-Signal 24
September 7, 2021Administration of Ivabradine in HFrEF
-
Cardio-Signal 23
September 7, 2021ICD implantation in HCM
-
Cardio-Signal 22
September 4, 2021Anticoagulation in transient AF
-
Cardio-Signal 21
August 28, 2021changing between P2Y12 inhibitors
-
Cardio-Signal 20
August 23, 2021DPI in AF
-
Cardio-Signal 19
August 22, 2021Changing between P2Y12 inhibitors
-
Cardio-Signal 18
August 19, 2021Anticoagulation in superficial venous thromboembolism
-
Cardio-Signal 17
August 15, 2021Mitral Regurgitation follow-up
-
Cardio-Signal 16
August 12, 2021Extended anticoagulation in PTE
-
Cardio-Signal 15
August 11, 2021Thromboprophylaxis in COVID-19
-
Cardio-Signal 14
August 9, 2021ASCVD risk assessment
-
Cardio-Signal 13
August 2, 2021N-acetyl-L-cysteine for the prevention of contrast nephropathy
-
Cardio-Signal 12
August 1, 2021Apixaban dose adjustment
-
Cardio-Signal 11
July 29, 2021Management of dyslipidemia in CCS
-
Cardio-Signal 10
July 27, 2021EVAR follow-up
-
Cardio-Signal 9
July 25, 2021Screening for abdominal aortic aneurysm
-
Cardio-Signal 8
July 22, 2021Screening for peripheral arterial disease
-
Cardio-Signal 7
July 20, 2021pre-operative management of SGLT2 inhibitors
-
Cardio-Signal 6
July 19, 2021concurrent administration of ASA and Ticagrelor
-
Cardio-Signal 5
July 18, 2021prescribing NOACs in AF
-
Cardio-Signal 4
July 13, 2021Iron deficiency anemia in HFrEF
-
Cardio-Signal 3
July 11, 2021pre-operative cardiac risk evaluation
-
Cardio-Signal 2
July 11, 2021Management of asymptomatic thoracic aortic aneurysm
-
Cardio-Signal 1
July 4, 2021Antibiotic prophylaxis for infective endocarditis
-
Guideline Directed Medical Therapy in Patients with HF
February 17, 2021Quick review on place of MRAs in patients with HFrEF
-
Guideline Directed Medical Therapy in Patients with HF
February 7, 2021Quick review on place of Beta-Blockers in patients with HFrEF
-
Guideline Directed Medical Therapy in Patients with HF
February 1, 2021Updates on ACEI/ARB place in patients with HFrEF (2021 Guideline)
-
New FDA approved indication for Ticagrelor
November 6, 2020Ticagrelor approved for recurrent stroke prevention
-
Treatment goals for LDL cholesterol across categories of total CV risk
November 4, 2020Overview of 2019 ESC/EAS Guidelines for the management of dyslipidemia
-
Monitor eGFR in Patients Treated with Metformin
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Patient factors influencing the selection of glucose-lowering drugs other than SGLT2i and metformin in T2D and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Glycemic Management for patients with T2DM and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Monitoring of ACEI/ ARB Treatment in Patients with T2DM and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
A music from the heart
August 8, 2020The S3 sound mixed into a delightful eastern melody by a talented Iranian physician
-
Dosage Modification of DOACs in Different Clinical Scenarios & in Renal Impairment
July 3, 2020Algorithmic approach to DOACs Dose Adjustment in CKD
-
Cardiovascular medication interactions with antiviral agents used for COVID-19
March 3, 2020Quick review of CV medications interactions with medications used for COVID-19
-
Cardiovascular medication interactions with antiviral agents used for COVID-19: Second Update
March 3, 2020Quick review of CV medications interactions with medications used for COVID-19
-
AF Patients on NOACs Undergoing Elective PCI or Angiography: When to Hold?
September 3, 2019Pre-procedural management of DOACs